Idt Australia Ltd has released a press release.
FDA review clears Pindolol for US launch
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from IDT Australia
- Appendix 3Z
- Generics Sales Update
- Completion of Initial CMAX Transaction
- Mayne Pharma Announces U.S. Launch of IDTs Temozolomide
- IDT: 1st generic proprietary prod shipped to US, temozolomide
Later from IDT Australia
- US launch of Pindolol
- Corporate Governance Statement
- Director Retirement - Graeme Blackman
- Resignation of Managing Director
- IDT Australia: Updated Charter Audit and Risk Committee
Follow IDT Australia into a list and get an email when it puts out news.
Follow IDT Australia